Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Quoin Pharmaceuticals Ltd in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
DI
Dauntless Investment Group, LLC
|
215.0K | 0.31% | +18.4K (+9.4%) | Q1 '26 | 0.8% | |
|
Shares held by quarter
Peak holding215.0K (Q2'26)
Change over 8 quarters+215.0K
Share of the company0.310%
|
||||||
|
IC
Ikarian Capital, LLC
|
211.5K | 0.30% | Unchanged | Q4 '25 | 0.1% | |
|
Shares held by quarter
Peak holding275.0K (Q4'24)
Change over 8 quarters+211.5K
Share of the company0.300%
|
||||||
20 more super investors behind a free account
See every manager holding Quoin Pharmaceuticals Ltd, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
AW
abrdn World Healthcare Fund
abrdn World Healthcare Fund
|
$196K | 40.4K | 0.06% | 0.03% | June 30, 2026 |
|
AL
abrdn Life Sciences Investors
abrdn Life Sciences Investors
|
$167K | 34.6K | 0.05% | 0.02% | June 30, 2026 |
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
DC
Denise Carter
5%+ holder
13D · 4.9%
|
939.2K | 1.34% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
MM
Michael Myers
5%+ holder
13D · 4.9%
|
939.2K | 1.34% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
Loading...